Synergistic combination dry powders for inhaled antimicrobial therapy: Formulation, characterization and in vitro evaluation

European Journal of Pharmaceutics and Biopharmaceutics

Volumn 83, Issue 2, 2013, Pages 275-284

  Lee, Sie Huey ^a   Teo, Jeanette ^b   Heng, Desmond ^a   Ng, Wai Kiong ^a   Chan, Hak Kim ^c   Tan, Reginald B H ^a,d  

^a INSTITUTE OF CHEMICAL AND ENGINEERING SCIENCES   (Singapore)

^b NATIONAL UNIVERSITY HOSPITAL   (Singapore)

^c UNIVERSITY OF SYDNEY   (Australia)

^d NATIONAL UNIVERSITY OF SINGAPORE   (Singapore)

Author keywords

Antimicrobial; Combinatorial therapy; Dry powder inhaler; Spray drying; Synergy

Indexed keywords

CIPROFLOXACIN; GATIFLOXACIN; LYSOZYME; ANTIINFECTIVE AGENT; POWDER;

ACINETOBACTER BAUMANNII; AEROSOL; ANTIMICROBIAL ACTIVITY; ANTIMICROBIAL THERAPY; ARTICLE; CONTROLLED STUDY; DISPERSION; DRUG POTENTIATION; DRUG SCREENING; DRUG SYNTHESIS; IN VITRO STUDY; KLEBSIELLA PNEUMONIAE; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; PARTICLE SIZE; PERFORMANCE; PHYSICAL CHEMISTRY; POWDER INHALER; PSEUDOMONAS AERUGINOSA; RESPIRATORY TRACT INFECTION; SPRAY DRYING; STAPHYLOCOCCUS AUREUS; SURFACE PROPERTY; BACTERIA; BACTERIAL INFECTIONS; CHEMISTRY; DRUG EFFECTS; DRY POWDER INHALER; INHALATIONAL DRUG ADMINISTRATION; MEDICINAL CHEMISTRY; PHARMACOLOGY; POWDER; PROCEDURES; RESPIRATORY TRACT INFECTIONS;

ADMINISTRATION, INHALATION; ANTI-INFECTIVE AGENTS; BACTERIA; BACTERIAL INFECTIONS; CHEMISTRY, PHARMACEUTICAL; DRUG SYNERGISM; DRY POWDER INHALERS; POWDERS; RESPIRATORY TRACT INFECTIONS;

EID: 84873722026     PISSN: 09396411     EISSN: 18733441     Source Type: Journal    
DOI: 10.1016/j.ejpb.2012.09.002     Document Type: Article

References (51)

1. R.W. Pinner, S.M. Teutsch, L. Simonsen, L.A. Klug, J.M. Graber, M.J. Clark, and R.L. Berkelman Trends in infectious diseases mortality in the United States Journal of the American Medical Association 275 1996 189 193
2. WHO, Removing Obstacles to Healthy Development, World Health Organization, Geneva, Switzerland, < http://www.who.int >, 1999 (Retrieved 30.04.12).
3. D.F. Gordon, The Global Infectious Disease Threat and its Implications for the United States, National Intelligence Council, Washington, DC, USA, < http://www.dni.gov/nic >, 2000 (Retrieved 30.04.12).
4. NIH, Emerging and Re-emerging Infectious Diseases, National Institutes of Health, Bethesda, MD, USA, < http://www3.niaid.nih.gov >, 2008 (Retrieved 30.04.12).
5. A.S. Fauci, N.A. Touchette, and G.K. Folkers Emerging infectious diseases: a 10-year perspective from the National Institute of Allergy and Infectious Diseases Emerging Infectious Diseases 11 2005 519 525
6. R. Chait, A. Craney, and R. Kishony Antibiotic interactions that select against resistance Nature 446 2007 668 671
7. V. Lorian Antibiotics in Laboratory Medicine 2005 Williams and Wilkins Baltimore, MD
8. G. Marshall, J.W.S. Blacklock, C. Cameron, N.B. Capon, R. Cruickshank, J.H. Gaddum, F.R.G. Heaf, A. Bradford Hill, L.E. Houghton, J. Clifford Hoyle, H. Raistrick, J.G. Scadding, W.H. Tytler, G.S. Wilson, and P. D'Arcy Hart Streptomycin treatment of pulmonary tuberculosis: a medical research council investigation British Medical Journal 2 1948 769 782
9. B. Fantin, and C. Carbon In vivo antibiotic synergism: contribution of animal models Antimicrobial Agents and Chemotherapy 36 1992 907 912
10. M.H. Lepper, and H.F. Dowling Treatment of pneumococcic meningitis with penicillin compared with penicillin aureomycin Archives of Internal Medicine 88 1951 489 494
11. D. Traini, and P.M. Young Delivery of antibiotics to the respiratory tract: an update Expert Opinion on Drug Delivery 6 2009 897 905
12. T. Abu-Salah, and R. Dhand Inhaled antibiotic therapy for ventilator-associated tracheobronchitis and ventilator-associated pneumonia: an update Advances in Therapy 28 2011 728 747
13. R. Beasley, C. Burgess, and S. Holt Call for worldwide withdrawal of benzalkonium chloride from nebulizer solutions Journal of Allergy and Clinical Immunology 107 2001 222 223
14. M.J. Asmus, J. Sherman, and L. Hendeles Bronchoconstrictor additives in bronchodilator solutions Journal of Allergy and Clinical Immunology 104 1999 S53 S60
15. G. Loughlin, and H. Eigen Respiratory Disease in Children: Diagnosis and Management 1994 Williams and Wilkins Baltimore MD
16. A.L. Coates, P.D. Allen, C.F. MacNeish, S.L. Ho, and L.C. Lands Effect of size and disease on estimated deposition of drugs administered using jet nebulization in children with cystic fibrosis Chest 119 2001 1123 1130
17. R.L. Elmore, M.E. Contois, J. Kelly, A. Noe, and A. Poirier Stability and compatibility of admixtures of intravenous ciprofloxacin and selected drugs Clinical Therapeutics 18 1996 246 255
18. D.E. Geller, M.W. Konstan, J. Smith, S.B. Noonberg, and C. Conrad Novel tobramycin inhalation powder in cystic fibrosis subjects: pharmacokinetics and safety Pediatric Pulmonology 42 2007 307 313
19. N.R.C. Labiris, A.M. Holbrook, H. Chrystyn, S.M. Macleod, and M.T. Newhouse Dry powder versus intravenous and nebulized gentamicin in cystic fibrosis and bronchiectasis-a pilot study American Journal of Respiratory and Critical Care Medicine 160 1999 1711 1716
20. A.J. Hickey, D.M. Lu, E.D. Ashley, and J. Stout Inhaled azithromycin therapy Journal of Aerosol Medicine-Deposition Clearance and Effects in the Lung 19 2006 54 60
21. E.M. Westerman, A.H. de Boer, P.P.H. Le Brun, D.J. Touw, H.W. Frijlink, and H.G.M. Heijerman Dry powder inhalation of colistin sulphomethate in healthy volunteers: a pilot study International Journal of Pharmaceutics 335 2007 41 45
22. H. Adi, P.M. Young, H.-K. Chan, P. Stewart, H. Agus, and D. Traini Cospray dried antibiotics for dry powder lung delivery Journal of Pharmaceutical Sciences 97 2008 3356 3366
23. M.D. Tsifansky, Y. Yeo, O.V. Evgenov, E. Bellas, J. Benjamin, and D.S. Kohane Microparticles for inhalational delivery of antipseudomonal antibiotics Aaps Journal 10 2008 254 260
24. British Pharmacopoeia Appendix XII C, Spottiswoode, London, 2009.
25. P. Resmini, L. Pellegrino, J.A. Hogenboom, and R. Andreini Thermal denaturation of whey protein in pasteurized milk-fast evaluation by HPLC Italian Journal of Food Science 1 1989 51 62
26. Clinical and Laboratory Standards Institute, CLSI, Wayne, PA, 2009.
27. J.B. Kirsner The origin of 20th century discoveries transforming clinical gastroenterology American Journal of Gastroenterology 93 1998 862 871
28. D. Heng, S.H. Lee, W.K. Ng, and R.B.H. Tan The nano spray dryer B-90 Expert Opinion on Drug Delivery 8 2011 965 972
29. S.H. Lee, D. Heng, W.K. Ng, H.-K. Chan, and R.B.H. Tan Nano spray drying: a novel method for preparing protein nanoparticles for protein therapy International Journal of Pharmaceutics 403 2011 192 200
30. M. Kumon, P.C.L. Kwok, H. Adi, D. Heng, and H.-K. Chan Can low-dose combination products for inhalation be formulated in single crystalline particles? European Journal of Pharmaceutical Sciences 40 2010 16 24
31. A. Tossavainen Determination of quartz on membrane filters by X-ray diffraction Scandinavian Journal of Work, Environment & Health 5 1979 379 385
32. B.A. Sarsfield, M. Davidovich, S. Desikan, M. Fakes, S. Futernik, J.L. Hilden, J.S. Tan, S. Yin, G. Young, B. Vakkalagadda, and K. Volk Powder X-ray diffraction detection of crystalline phase in amorphous pharmaceuticals International Centre for Diffraction Data 2006 322 327
33. S.E. Letant, J.L. Herberg, T.S. Wilson, C.T. Alviso, S.C. Chinn, R.S. Maxwell, Initial Aging Studies of Unfilled VCE, LLNL-TR-407872, 2008.
34. P.C.L. Kwok, A. Tunsirikongkon, W. Glover, and H.-K. Chan Formation of protein nano-matrix particles with controlled surface architecture for respiratory drug delivery Pharmaceutical Research 28 2011 788 796
35. N.Y.K. Chew, and H.K. Chan Use of solid corrugated particles to enhance powder aerosol performance Pharmaceutical Research 18 2001 1570 1577
36. N.Y.K. Chew, P. Tang, H.K. Chan, and J.A. Raper How much particle surface corrugation is sufficient to improve aerosol performance of powders? Pharmaceutical Research 22 2005 148 152
37. B.K. Rubin The pharmacologic approach to airway clearance: mucoactive agents Paediatric Respiratory Reviews 7 2006 S215 S219
38. E. Gullberg, S. Cao, O.G. Berg, C. Ilback, L. Sandegren, D. Hughes, and D.I. Andersson Selection of resistant bacteria at very low antibiotic concentrations Plos Pathogens 7 2011
39. S.P. Newman, and H.K. Chan In vitro/in vivo comparisons in pulmonary drug delivery Journal of Aerosol Medicine and Pulmonary Drug Delivery 21 2008 77 84
40. D. Morton, Q. Zhou, and R. Musa Antibiotic Microparticles for Inhalation vol. 20110139152 2011 Chiesi Farmaceutici S.p.A. (Parma, IT) United States
41. D. Heng, S.H. Lee, J.W. Kwek, W.K. Ng, H.-K. Chan, and R.B.H. Tan Assessing the combinatorial influence of climate, formulation and device on powder aerosolization using the Taguchi experimental design Powder Technology 226 2012 253 260
42. D.R. Chung, H. Song, S.H. Kim, V. Thamlikitkul, S.-G. Huang, and H. Wang High prevalence of multidrug-resistant nonfermenters in hospital-acquired pneumonia in Asia American Journal of Respiratory and Critical Care Medicine 184 2011 1409 1417
43. G.A. Pankey, and D.S. Ashcraft In vitro synergy of ciprofloxacin and gatifloxacin against ciprofloxacin-resistant Pseudomonas aeruginosa Antimicrobial Agents and Chemotherapy 49 2005 2959 2964
44. H. Heijerman Infection and inflammation in cystic fibrosis: a short review Journal of Cystic Fibrosis 2 2005 3 5
45. S.J. Skerrett Lysozyme in pulmonary host defense-new tricks for an old dog American Journal of Respiratory and Critical Care Medicine 169 2004 435 436
46. V.A. Proctor, and F.E. Cunningham The chemistry of lysozyme and its use as a food preservative and a pharmaceutical Critical Reviews in Food Science and Nutrition 26 1988 359 395
47. D. Verhamme, J. Storck, A. Lauwers, and L. Racchelli Lysozyme (N-acetylmuramyl b(1®4) glycanohydrolase EC 3.2.1.17) International Pharmacy Journal 2 1988 168 171
48. G.R. Cannefax, and A.W. Hanson Ineffectiveness of lysozyme therapy in experimental syphilis in the rabbit British Journal of Venereal Diseases 39 1963 192 194
49. D. Nakimbugwe, B. Massehalck, M. Atanassova, A. Zewdie-Bosuner, and C.W. Michiels Comparison of bactericidal activity of six lysozymes at atmospheric pressure and under high hydrostatic pressure International Journal of Food Microbiology 108 2006 355 363
50. B. Masschalck, R. Van Houdt, E.G.R. Van Haver, and C.W. Michiels Inactivation of gram-negative bacteria by lysozyme, denatured lysozyme, and lysozyme-derived peptides under high hydrostatic pressure Applied and Environmental Microbiology 67 2001 339 344
51. T.D. Ho, J.L. Hastie, P.J. Intile, and C.D. Ellermeier The Bacillus subtilis extracytoplasmic function sigma factor sigma(V) is induced by lysozyme and provides resistance to lysozyme Journal of Bacteriology 193 2011 6215 6222